Home » Tenders » Americas » USA » Tender 22881194

Antidote Treatment Nerve Agent Auto-Injector Tender in USA - 22881194

The DEFENSE LOGISTICS AGENCY has issued a Tender notice for the procurement of a Antidote Treatment Nerve Agent Auto-Injector in the USA. This Tender notice was published on 29 Apr 2018 and is scheduled to close on 09 May 2018, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 22881194, while the tender notice number is SPE2DP-18-R-0200 and Registering on the platform.

Procurement Summary

Country: USA

Summary: Antidote Treatment Nerve Agent Auto-Injector

Deadline: 09 May 2018

Posting Date: 29 Apr 2018

Other Information

Notice Type: Tender

TOT Ref.No.: 22881194

Document Ref. No.: SPE2DP-18-R-0200

Competition: ICB

Financier: Self Financed

Purchaser Ownership: -

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Tender Details

The defense logistics agency troop support is seeking sources capable of providing the antidote treatment nerve agent auto-injector (atnaa). Dla troop support is contemplating awarding a requirements contract with a one-year base and six one year options for the atnaa. The estimated average annual quantity to be ordered is 1.2 million units. However, the quantity may increase or decrease as the services requirements change.
The atnaa shall be licensed by the food and drug administration (fda). Each auto-injector shall deliver 2.1 mg of atropine and 600mg of pralidoxime chloride in separate chambers, and be suitable for intramuscular administration.
Must have fda approval to sell the atnaa before award of the contract.
If your firm currently manufactures or distributes the atnaa, please provide information with respect to the following:
a) place of manufacture
b) estimated annual capacity
c) fda registration
d) product name and description including description of any special features
e) current unit sale price
f) estimated inventory level and storage requirements
*** new products under development***
for products under development, describe the current stage of development and whether the product has undergone independent laboratory testing or fda testing/trials etc. Firms and organizations that currently develop or manufacture the atnaa or that have technologies, pharmaceuticals, or manufacturing capabilities under development are invited to submit information to dla troop support.
Data obtained from this request for information (rfi) will be used by dla troop support in making recommendations and decisions on the development of an appropriate planning and procurement strategy for the atnaa. All information submitted shall remain with the u.s. Government and will not be returned. It will be kept confidential as allowed by relevant federal law and will be eligible for additional special protections...

Documents

Tender Notice

Browse More

All Tenders From USA

All Tenders From Americas

Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA

Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services

View Tenders By